In vitro assays revealed that M701 specifically trafficked CD3-positive cells to EpCAM-positive cells and caused lysis of only tumor cells with moderate-to-high EpCAM expression, indicating that M701 has few side effects on normal tissue. This evidence concerns the gene EPCAM and neoplasm.